Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

BBHvsRSPHETF Comparison

ETF 1
BBH

VanEck Biotech ETF

This fund is part of
US Health Care
+0.53%
VS
ETF 2
RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of
US Health Care
+0.53%

VanEck Biotech ETF (BBH) and Invesco S&P 500® Equal Weight Health Care ETF (RSPH) belong to the same industry segment: US Health Care. BBH's top 1 sector exposures are Healthcare. In contrast, RSPH's top sector exposures are Healthcare and Consumer Non-Cyclicals. BBH is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.4% for RSPH. BBH is up 9.98% year-to-date (YTD) with -$7M in YTD flows. RSPH performs better with 10.95% YTD performance, and -$43M in YTD flows. Run a side-by-side ETF comparison of BBH and RSPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

BBH vs RSPH performance and flow charts

Performance

-4.0-2.00.02.0%Jul 6Jul 13Jul 20Jul 27Aug 3

Cumulative Flows

0 M5 M10 M15 M20 MJul 6Jul 13Jul 20Jul 27Aug 3

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 08/04/2026
1M3MYTD1Y3Y5Y
Perf.
BBH
RSPH
-1.02%+2.51%
+12.06%+16.92%
+9.98%+10.95%
+26.54%+25.07%
+32.94%+22.19%
-1.92%+17.87%
Flows
BBH
RSPH
-+$23M
-$4M-$11M
-$7M-$43M
-$28M-$67M
-$180M-$348M
-$139M-$250M
Volatility and drawdown
3M1Y3Y5Y
Volatility
BBH
RSPH
+21.02%+17.91%
+19.52%+15.88%
+19.25%+15.42%
+21.50%+16.56%
Max drawdown
BBH
RSPH
-5.29%-3.58%
-10.54%-10.87%
-22.78%-16.96%
-39.88%-21.91%
Max drawdown duration
BBH
RSPH
28d20d
150d116d
440d434d
1821d817d
Trading data

Create an account to view trading data

Join for free
BBH
RSPH
Last sale
8/5/2026 at 4:56 PM
$210.50
$35.14
Previous close
08/04/2026
$208.03
$35.21
Consolidated volume
08/04/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of July 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
BBH
RSPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 8/5/2026 at 4:56 PM
Live
Closed
BBH
RSPH
Last price
$210.50
$35.14
1D performance
+1.19%
-0.20%
AuM$404.99 M$775.83 M
E/R0.35%0.4%
Characteristics
BBH
RSPH
Management strategyPassivePassive
ProviderVanEckInvesco
BenchmarkMVIS US Listed Biotech 25 IndexS&P 500 Equal Weight Health Care Index
N° of holdings2459
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateDecember 20, 2011November 1, 2006
ESGNoNo
Advertisement
Exposure

Countries

BBH
USA
87.33%
Other
12.67%
RSPH
USA
96.71%
Other
3.29%

Sectors

BBH
Healthcare
100%
RSPH
Healthcare
98.29%
Other
1.71%
Advertisement

Diversification

BBH

Total weight of top 15 holdings out of 15

85.08%
RSPH

Total weight of top 15 holdings out of 15

27.58%

Top 15 holdings

Data as of June 30, 2026
BBH
Amgen, Inc.
15.15%
Gilead Sciences, Inc.
12.75%
Vertex Pharmaceuticals, Inc.
9.15%
Regeneron Pharmaceuticals, Inc.
6.26%
Revolution Medicines, Inc.
5.41%
Natera, Inc.
4.92%
argenx SE
4.88%
IQVIA Holdings, Inc.
4.30%
Alnylam Pharmaceuticals, Inc.
3.73%
Biogen, Inc.
3.63%
Moderna, Inc.
3.34%
Illumina, Inc.
3.26%
BeOne Medicines Ltd.
2.85%
United Therapeutics Corp.
2.84%
Insmed, Inc.
2.62%
RSPH
Moderna, Inc.
2.35%
Bio-Techne Corp.
2.17%
Charles River Laboratories International, Inc.
1.86%
Vertex Pharmaceuticals, Inc.
1.81%
AbbVie, Inc.
1.81%
Mettler-Toledo International, Inc.
1.79%
Revvity, Inc.
1.79%
Biogen, Inc.
1.79%
Cardinal Health, Inc.
1.77%
DaVita, Inc.
1.76%
Baxter International, Inc.
1.74%
Merck & Co., Inc.
1.74%
Incyte Corp.
1.73%
Henry Schein, Inc.
1.73%
Stryker Corp.
1.73%
Frequently asked questions about BBH and RSPH

How have the BBH and RSPH ETFs performed in 2026?

As of August 4, 2026, BBH is up 9.98% year-to-date (YTD), while RSPH has returned 10.95%. That puts RSPH better performer ahead so far this year.

Which ETF is attracting more investor money: BBH or RSPH?

Year-to-date, the BBH ETF saw -$7M in flows, compared to -$43M for RSPH.

Which ETF is more volatile: BBH or RSPH?

Over the past year, BBH had a volatility of 19.52%, while RSPH experienced 15.88%.

Which ETF is bigger: BBH or RSPH?

As of August 4, 2026, BBH holds $404.99 M in assets under management (AUM), while RSPH manages $775.83 M.

What sectors do the BBH and RSPH ETFs invest in?

BBH leans toward sectors like Healthcare. Meanwhile, RSPH focuses on Healthcare.

What are the top holdings of the BBH ETF and RSPH ETF?

BBH top holdings include Amgen, Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals, Inc.. RSPH holds in its top three: Moderna, Inc., Bio-Techne Corp. and Charles River Laboratories International, Inc..

Which ETF is more diversified: BBH or RSPH?

BBH holds 24 securities with 85.08% of its assets in the top 15. RSPH has 59 securities and a top 15 weight of 27.58%.

Advertisement
Latest news about BBH & RSPH
Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder